Targeting the Eph-ephrin System with Protein-Protein Interaction (PPI) Inhibitors

Author(s): Massimiliano Tognolini and Alessio Lodola

Volume 16, Issue 10, 2015

Page: [1048 - 1056] Pages: 9

DOI: 10.2174/1389450116666150825144457

Price: $65

Abstract

Eph-ephrin system is emerging as a new potential target in several diseases including cancer, diabetes, neurodegenerative diseases and inflammation. In the last decade, several efforts have been made to develop small molecule antagonists of Eph receptors. Both natural and synthetic compounds were discovered with (poly) phenol and steroidal derivatives on one side and the α1 agonist doxazosin, 2,5-dimethylpyrrol- 1-yl-benzoic acids and amino acid conjugates of lithocholic acid on the other. In the present paper we critically present available data for these compounds and discuss their potential usefulness as pharmacological tools or as candidates for a lead-optimization program.

Keywords: Eph, ephrin, drug discovery, small molecules, protein-protein, antagonist.

Graphical Abstract

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy